TRINITY BIOTECH PLC
TRIBNasdaq
$0.34
↓ -9.5%Jul 17 close · end-of-day
Price
1Y↓ -91.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company sells its products through its direct sales force; and a network of independent distributors.
- CEO
- Aris Kekedjian
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 480
- Website
- trinitybiotech.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.